Pathogenic principles in giant cell arteritis
- 1 August 2000
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 75, S9-S15
- https://doi.org/10.1016/s0167-5273(00)00198-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Formation of New Vasa Vasorum in Vasculitis: Production of Angiogenic Cytokines by Multinucleated Giant CellsThe American Journal of Pathology, 1999
- Tissue-Destructive Macrophages in Giant Cell ArteritisCirculation Research, 1999
- Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitisJournal of Clinical Investigation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.Journal of Clinical Investigation, 1997
- Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis.Journal of Clinical Investigation, 1996
- Hla–drb1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritisArthritis & Rheumatism, 1994
- Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes.The Journal of Experimental Medicine, 1994
- Correlation of interleukin‐6 production and disease activity in polymyalgia rheumatica and giant cell arteritisArthritis & Rheumatism, 1993
- The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.Journal of Clinical Investigation, 1992